Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Carisma Therapeutics Inc. (SESN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
SC 13G
| Longview Innovation Corp. reports a 7.2% stake in Carisma Therapeutics Inc. |
| 03/13/2023 |
SC 13G
| ModernaTX, Inc. reports a 12.6% stake in CARISMA THERAPEUTICS INC. |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2022 |
SC 13G
| VANGUARD GROUP INC reports a 6.2% stake in Sesen Bio Inc. |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/28/2021 |
SC 13G
| INTEGRATED ASSETS II LLC reports a |
| 06/28/2019 |
SC 13G
| CVI Investments, Inc. reports a 9.1% stake in Sesen Bio, Inc. |
| 02/14/2019 |
SC 13G
| Consonance Capital Management LP reports a 9.7% stake in SESEN BIO, INC |
| 04/04/2018 |
SC 13G
| KINGDON CAPITAL MANAGEMENT, L.L.C. reports a 5.1% stake in Eleven Biotherapeutics, Inc. |
| 03/22/2018 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 7.4% stake in Eleven Biotherapeutics, Inc. |
| 11/08/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/25/2016 |
SC 13G
| Eleven Biotherapeutics, Inc. reports a 7.5% stake in ELEVEN BIOTHERAPEUTICS, INC. |
|
|